|
Volumn 7, Issue 3, 2001, Pages 120-124
|
Issues in the economic evaluation of treatments for menopausal symptoms
|
Author keywords
Economic evaluation; Hormone replacement therapy; Menopause; Oestrogen; Tibolone
|
Indexed keywords
ESTROGEN;
GESTAGEN;
HORMONE;
TIBOLONE;
BREAST CANCER;
CANCER RISK;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
COST UTILITY ANALYSIS;
DECISION MAKING;
DRUG COST;
DRUG EFFICACY;
ECONOMIC EVALUATION;
ENDOMETRIUM CANCER;
EVALUATION;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
LONG TERM CARE;
MENOPAUSAL SYNDROME;
PATIENT COMPLIANCE;
QUALITY OF LIFE;
RESOURCE MANAGEMENT;
REVIEW;
RISK BENEFIT ANALYSIS;
SHORT COURSE THERAPY;
SYMPTOM;
|
EID: 0034815188
PISSN: 13621807
EISSN: None
Source Type: Journal
DOI: 10.1258/136218001100321407 Document Type: Review |
Times cited : (1)
|
References (26)
|